These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 12056005)

  • 1. [Contribution of Japanese researchers to the progress of studies in endocrinology and metabolism in the field of internal medicine in the last 100 years: Development of statins].
    Yamamoto A
    Nihon Naika Gakkai Zasshi; 2002 Apr; 91(4):1134-6. PubMed ID: 12056005
    [No Abstract]   [Full Text] [Related]  

  • 2. Statins: in the beginning.
    Lyons KS; Harbinson M
    J R Coll Physicians Edinb; 2009 Dec; 39(4):362-4. PubMed ID: 20509462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statins have offered great benefits. 2002.
    Yamamoto A
    Atheroscler Suppl; 2004 Oct; 5(3):35-7. PubMed ID: 15531272
    [No Abstract]   [Full Text] [Related]  

  • 4. Competitive inhibition of 3-hydroxy-3-methylglutaryl coenzyme A reductase by ML-236A and ML-236B fungal metabolites, having hypocholesterolemic activity. 1976.
    Endo A; Kuroda M; Tanzawa K
    Atheroscler Suppl; 2004 Oct; 5(3):39-42. PubMed ID: 15531273
    [No Abstract]   [Full Text] [Related]  

  • 5. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). 1994.
    Pedersen TR; Kjekshus J; Berg K; Haghfelt T; Faergeman O; Faergeman G; Pyörälä K; Miettinen T; Wilhelmsen L; Olsson AG; Wedel H;
    Atheroscler Suppl; 2004 Oct; 5(3):81-7. PubMed ID: 15531279
    [No Abstract]   [Full Text] [Related]  

  • 6. Lowering plasma cholesterol by raising ldl receptors. 1981.
    Brown MS; Goldstein JL
    Atheroscler Suppl; 2004 Oct; 5(3):57-9. PubMed ID: 15531276
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of an inhibitor of 3-hydroxy-3-methylglutaryl coenzyme a reductase on serum lipoproteins and ubiquinone-10 levels in patients with familial hypercholesterolemia. 1981.
    Mabuchi H; Haba T; Tatami R; Miyamoto S; Sakai Y; Wakasugi T; Watanabe A; Koizumi J; Takeda R
    Atheroscler Suppl; 2004 Oct; 5(3):51-5. PubMed ID: 15531275
    [No Abstract]   [Full Text] [Related]  

  • 8. Foundations for blockbuster drugs in federally sponsored research.
    Thompson RB
    FASEB J; 2001 Aug; 15(10):1671-6. PubMed ID: 11481212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thirty Years of Statins, Festschrift in honor of Dr. Akira Endo.
    Atheroscler Suppl; 2004 Oct; 5(3):1-130. PubMed ID: 15531260
    [No Abstract]   [Full Text] [Related]  

  • 10. The discovery of statins.
    Stossel TP
    Cell; 2008 Sep; 134(6):903-5. PubMed ID: 18805080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Contribution of Japanese researchers to the progress of studies in endocrinology and metabolism in the field of internal medicine in the last 100 years: Artificial endocrine pancreas].
    Shichiri M; Sakakida M; Nishida K; Araki E
    Nihon Naika Gakkai Zasshi; 2002 Apr; 91(4):1137-9. PubMed ID: 12056006
    [No Abstract]   [Full Text] [Related]  

  • 12. [25 years of progress in the treatment of metabolic disorders: statins revolutionise cardiovascular prevention].
    Parhofer K
    MMW Fortschr Med; 2008 Nov; 150(48):95, 98. PubMed ID: 19125511
    [No Abstract]   [Full Text] [Related]  

  • 13. [Contribution of Japanese researchers to the progress of studies in endocrinology and metabolism in the field of internal medicine in the last 100 years: Abnormal insulin].
    Nanjyo K
    Nihon Naika Gakkai Zasshi; 2002 Apr; 91(4):1149-51. PubMed ID: 12056009
    [No Abstract]   [Full Text] [Related]  

  • 14. [Contribution of Japanese researchers to the progress of studies in endocrinology and metabolism in the field of internal medicine in the last 100 years: Hashimoto's disease].
    Amino N; Tada H; Hidaka Y
    Nihon Naika Gakkai Zasshi; 2002 Apr; 91(4):1127-30. PubMed ID: 12056003
    [No Abstract]   [Full Text] [Related]  

  • 15. The origin of the statins. 2004.
    Endo A
    Atheroscler Suppl; 2004 Oct; 5(3):125-30. PubMed ID: 15531285
    [No Abstract]   [Full Text] [Related]  

  • 16. The Discovery of Statins.
    Manu P; Rogozea L
    Am J Ther; 2016; 23(4):e980-1. PubMed ID: 27386961
    [No Abstract]   [Full Text] [Related]  

  • 17. [Contribution of Japanese researchers to the progress of studies in endocrinology and metabolism in the field of internal medicine in the last 100 years: Tarui's disease(muscular phosphofructokinase deficiency)].
    Tarui S
    Nihon Naika Gakkai Zasshi; 2002 Apr; 91(4):1145-8. PubMed ID: 12056008
    [No Abstract]   [Full Text] [Related]  

  • 18. [Contribution of Japanese researchers to the progress of studies in endocrinology and metabolism in the field of internal medicine in the last 100 years: Insulin autoimmune syndrome].
    Hirata Y; Uchigata Y
    Nihon Naika Gakkai Zasshi; 2002 Apr; 91(4):1131-3. PubMed ID: 12056004
    [No Abstract]   [Full Text] [Related]  

  • 19. The discovery and development of HMG-CoA reductase inhibitors. 1992.
    Endo A
    Atheroscler Suppl; 2004 Oct; 5(3):67-80. PubMed ID: 15531278
    [No Abstract]   [Full Text] [Related]  

  • 20. [About the discovery of hypolipidemic drugs].
    Mostaza Prieto JM
    Med Clin (Barc); 2008 May; 130(18):698-703. PubMed ID: 18501142
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.